Stimulation of fetal hemoglobin production by short chain fatty acids

Blood. 1995 Oct 15;86(8):3227-35.

Abstract

Butyrate, a four-carbon fatty acid, and its two-carbon metabolic product, acetate, are inducers of gamma-globin synthesis. To test whether other short-chain fatty acids share this property, we first examined whether propionic acid, a three-carbon fatty acid that is not catabolized to acetate, induces gamma-globin expression. Sodium propionate increased the frequency of fetal hemoglobin containing erythroblasts and the gamma/gamma + beta mRNA ratios in adult erythroid cell cultures and F reticulocyte production in a nonanemic juvenile baboon. Short-chain fatty acids containing five (pentanoic), six (hexanoic), seven (heptanoic), eight (octanoic), and nine (nonanoic) carbons induced gamma-globin expression (as measured by increase in gamma-positive erythroblasts and gamma/gamma + beta mRNA ratios) in adult erythroid burst-forming unit cultures. There was a clear-cut relationship between the concentration of fatty acids in culture and the degree of induction of gamma-globin expression. Three-, four-, and five-carbon fatty acids were better inducers of gamma globin in culture as compared with six- to nine-carbon fatty acids. These results suggest that all short-chain fatty acids share the property of gamma-globin gene inducibility. The fact that valproic acid, a derivative of pentanoic acid, also induces gamma-globin expression suggests that short-chain fatty acid derivatives that are already approved for human use may possess the property of gamma-globin inducibility and may be of therapeutic relevance to the beta-chain hemoglobinopathies.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anemia, Sickle Cell / blood
  • Animals
  • Anticonvulsants / metabolism
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • Butyrates / pharmacology
  • Butyric Acid
  • Cells, Cultured
  • Epilepsy / drug therapy
  • Erythroid Precursor Cells / drug effects*
  • Erythropoietin / pharmacology
  • Fatty Acids, Volatile / chemistry
  • Fatty Acids, Volatile / pharmacology*
  • Fetal Hemoglobin / biosynthesis*
  • Fetal Hemoglobin / genetics
  • Gene Expression Regulation / drug effects*
  • Globins / biosynthesis*
  • Globins / genetics
  • Hemoglobinopathies / therapy
  • Humans
  • Papio
  • Pentanoic Acids / pharmacology
  • Propionates / metabolism
  • Propionates / pharmacology
  • RNA, Messenger / biosynthesis
  • Reticulocytes / drug effects
  • Structure-Activity Relationship
  • Valproic Acid / metabolism
  • Valproic Acid / pharmacology
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Butyrates
  • Fatty Acids, Volatile
  • Pentanoic Acids
  • Propionates
  • RNA, Messenger
  • Butyric Acid
  • Erythropoietin
  • Valproic Acid
  • Globins
  • Fetal Hemoglobin
  • sodium propionate
  • n-pentanoic acid
  • propionic acid